Thermo Fisher Scientific (TMO) Completes Acquisition of Dionex Corporation
Thermo Fisher Scientific Inc. (NYSE: TMO) has successfully completed its acquisition of Dionex Corporation (NASDAQ: DNEX) through a short-form merger. Pursuant to the terms of the merger, all outstanding Dionex shares (other than those held by Thermo Fisher, Dionex or any wholly owned subsidiary of Dionex, and any shareholders who validly exercised their appraisal rights in connection with the merger) will be exchanged for $118.50 per share in cash.
In connection with the completion of the transaction, Dionex stock ceased to trade on the NASDAQ following market close today and will be delisted.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
In connection with the completion of the transaction, Dionex stock ceased to trade on the NASDAQ following market close today and will be delisted.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- BofA (BAC), Barclays (BCS) to Sell Remaining Archstone Interest in $1.58B Deal to Lehman Bros.
- Dell (DELL) Could Be Considering Bid for Quest Software (QSFT)
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
